DCRI Faculty Speak About Clinical Research During COVID-19
Duke-Margolis Paper Details Strategies to Treat COVID-19
Former FDA Commissioners Mark McClellan, MD, PhD, director of the Duke-Margolis Center for Health Policy, and Scott Gottlieb, MD, made recommendations for how the FDA should respond to the novel co
Paper Details Design of ADAPTABLE, First Pragmatic Trial to Use PCORnet®
Preventing Alzheimer’s Disease? Taking the First Step Through the TOMMORROW Trial
The study sought to simultaneously test a method for identifying individuals at high risk for Alzheimer’s disease while testing the efficacy of a potential treatment aimed at targets affecting cell
Patient-Reported Health Data in Pragmatic Trials: Helpful, But Not Without Limitations
A report from an NIH Health Care Systems Research Collaboratory roundtable recently published in
12-month SECURE-PCI Results add Context to Original Findings
New DCRI Registry Could Provide Path for Pediatric Migraine Drug Development
A recently published paper details the development and design of the FDA-funded Pediatric Migraine Registry, which has enrolled around 200 patients between the ages of 4 and 17.
Interventional Cardiologists Must Stay Up-to-date on Training to Avoid ‘Proficiency Divide’
The DCRI’s Sunil Rao, MD, writes that to deliver high quality care, interventional cardiologists must constantly evaluate their practice and learn new techniques and skills.
DCRI and Digital Solutions: A New World of Evidence Generation
From thought leadership on a national stage to driving adoption for digital health technologies, the DCRI is leading the way in the digital therapeutic space.